Cabaletta Bio Inc expected to post a loss of 39 cents a share - Earnings Preview

Cabaletta Bio

12/03/2024 12:40

* Cabaletta Bio Inc  CABA.OQ   CABA.O  is expected to show
no
change in quarterly revenue when it reports  results on March 14
(estimated) for the period ending December 31 2023
    * 
    * ​LSEG's mean analyst estimate for Cabaletta Bio Inc is for
a
loss of 39 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Cabaletta
Bio Inc
is $31.00​, above​ its last closing price of $20.38. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.41       -0.40      -0.37     Beat    8.3
 Jun. 30 2023  -0.44       -0.44      -0.37     Beat    16.4
 Mar. 31 2023  -0.48       -0.48      -0.45     Beat    6.3​
 Dec. 31 2022  -0.48       -0.45      -0.52     Missed  -15.1
 ​​Sep.        -0.47       -0.48      -0.39     Beat    19
 30 2022                                                
 Jun. 30 2022  -0.50       -0.50      -0.45     Beat    10.9​
 Mar. 31 2022  -0.56       -0.60      -0.45     Beat    24.5
 Dec. 31 2021  -0.64       -0.60      -0.49     Beat    19
 This summary was machine generated March 12 at 12:40 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)